NASDAQ:CXRX

(CXRX) (CXRX) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.19
$0.21
50-Day Range
$0.19
$0.19
52-Week Range
$0.19
$1.80
Volume
648,890 shs
Average Volume
267,843 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CXRX stock logo

About (CXRX) Stock (NASDAQ:CXRX)

CXRX Stock News Headlines

See More Headlines
Receive CXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (CXRX) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2016
Today
5/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CXRX
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Allan Oberman (Age 60)
    CEO & Director
  • Mr. Francesco Tallarico (Age 35)
    Chief Legal Officer & Sec.
  • Mr. Adrian A. de Saldanha (Age 57)
    Exec.
  • Mr. Adeel Ahmad (Age 44)
    Chief Financial Officer of Concordia International Segment
  • H.R.H. David J. Price (Age 55)
    Chief Financial Officer

CXRX Stock Analysis - Frequently Asked Questions

How were (CXRX)'s earnings last quarter?

(CXRX) (NASDAQ:CXRX) released its earnings results on Friday, August, 12th. The company reported $1.38 EPS for the quarter, meeting analysts' consensus estimates of $1.38. The firm earned $231.70 million during the quarter, compared to the consensus estimate of $229.76 million. (CXRX)'s revenue was up 208.1% compared to the same quarter last year.

What other stocks do shareholders of (CXRX) own?
This page (NASDAQ:CXRX) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners